Diabetic cardiomyopathy: Emerging therapeutic options

doi:10.4239/wjd.v15.i8.1677

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2428)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

HTML

2047

Figures (1-1)

138

Sum=2223

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=130

Aug 15, 2024 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Aug 15, 2024; 15(8): 1677-1682
Published online Aug 15, 2024. doi: 10.4239/wjd.v15.i8.1677

Open in New Tab Full Size Figure Download Figure

Figure 1 The metabolic, structural, and functional changes in the heart leading to the development of diabetic cardiomyopathy. Ca²⁺: Calcium; HFpEF: Heart failure with preserved ejection fraction; HFrEF: Heart failure with reduced ejection fraction.

Citation: Fernandez CJ, Shetty S, Pappachan JM. Diabetic cardiomyopathy: Emerging therapeutic options. World J Diabetes 2024; 15(8): 1677-1682
URL: https://www.wjgnet.com/1948-9358/full/v15/i8/1677.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i8.1677